Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • FRAUD AND ABUSE—D. Nev.: AKS claims can proceed against compounding pharmacy accused of kickbacks
    • ADMINISTRATION OF MEDICARE/MEDICAID PROGRAMS –DAB DECISIONS: DAB affirms revocation and preclusion of dentist with a felony conviction
    • CONTROLLED SUBSTANCES—FINAL RULE: DEA finalizes rule on cannabimimetic agents
    • EXPERT INSIGHTS: Cracking down on alleged wound care fraud: A new era of DOJ and HHS enforcement
    • MEDICAID– DAB DECISIONS: CMS properly disallowed nearly $24M in pharmacy dispensing fees
    • REGULATION TRACKER—Information on pending or recently adopted regulations and regulation amendments
    • WORTH NOTING—Other Health Law litigation and regulatory developments
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Health Law Daily Wrap Up, CONTROLLED SUBSTANCES—FINAL RULE: DEA finalizes rule on cannabimimetic agents, (Jan 20, 2026)

    By WK Editorial Staff

    The DEA is streamlining drug codes and adding 18 substances to its definition of “cannabimimetic agents.”

    The Drug Enforcement Administration is publishing this final rule to amend its regulations related to “cannabimimetic agents ...

    By WK Editorial Staff

    The DEA is streamlining drug codes and adding 18 substances to its definition of “cannabimimetic agents.”

    The Drug Enforcement Administration is publishing this final rule to amend its regulations related to “cannabimimetic agents” by including the term’s definition, identifying 18 additional substances that meet the definition, and consolidating most existing administration controlled substances code numbers (drug codes) into a single drug code number for substances that meet this definition. The listing for two schedule I “cannabimimetic agents” that are under international control, JWH–018 and AM2201, are moved to the ‘‘hallucinogens’’ paragraph of schedule I but retain their existing drug codes to facilitate quota and international reporting requirements. While this final rule does not change the current and continuing schedule I status for the 18 additional substances meeting the definition of “cannabimimetic agents,” these and other substances meeting this definition will be assigned a new administration controlled substances code number once this final rule becomes effective (Final Rule, 91 Fed. Reg. 2297 (Jan. 20, 2026)).

    Dates. This final rule is effective February 19, 2026.

    FederalRegisterIssuances: FinalRules ControlledNews DrugBiologicNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use